EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating treatment effectiveness: Complementing RCTs with real-world data

Christina G Rivera, Essy Mozaffari, Stephanie H Read, Andre C Kalil

American Journal of Health-System Pharmacy · 2026

DOI: 10.1093/ajhp/zxag035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2026. Verfasst von Christina G Rivera und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Comparative Effectiveness Research, Randomized Controlled Trials as Topic, Research Design. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

While randomized controlled trials remain the gold standard for assessing treatment efficacy, studies using real-world data (RWD) offer valuable insights into treatment effectiveness across broader, more diverse patient populations. This commentary explores the importance of using fit-for-purpose data and emphasizes the need for rigorous evaluation of RWD quality to support valid and actionable evidence generation. Summary The utility of RWD-based studies depends heavily on the fitness-for-purpose of the data source, which requires careful assessment of 5 key quality dimensions: relevance, extensiveness, timeliness, coherence, and reliability. Practical examples from coronavirus disease 2019 (COVID-19) comparative effectiveness research are used to illustrate each data quality domain.

Conclusions

As the need for RWD increases, especially for post–COVID-19 pandemic decision-making, ensuring high data quality and appropriate study design is critical. Proper evaluation of RWD sources enhances the credibility of findings and supports their use in meta-analyses, clinical guidelines, and healthcare policy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Comparative Effectiveness ResearchRandomized Controlled Trials as TopicResearch DesignHumansCOVID-19PandemicsTreatment OutcomeData AccuracyReproducibility of ResultsSARS-CoV-2

Stichwörter der Autor:innen

comparative effectiveness researchfeasibilityfitness-for-purposereal-world data

Autor:innen und Institutionen

  • Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Medical Affairs, Gilead Sciences, Foster City, CA, USA.
  • Evidence and Access, Certara, London, UK.
  • Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Zitieren

APA

Rivera, C. G., Mozaffari, E., Read, S. H., & Kalil, A. C. (2026). Evaluating treatment effectiveness: Complementing RCTs with real-world data. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag035

Vancouver

Rivera CG, Mozaffari E, Read SH, Kalil AC. Evaluating treatment effectiveness: Complementing RCTs with real-world data. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxag035

BibTeX
@article{Rivera2026,
  author = {Rivera, Christina G and Mozaffari, Essy and Read, Stephanie H and Kalil, Andre C},
  title = {Evaluating treatment effectiveness: Complementing RCTs with real-world data},
  journal = {American Journal of Health-System Pharmacy},
  year = {2026},
  doi = {10.1093/ajhp/zxag035}
}
Kostenlos starten →